Hong Wen

11PUBLICATIONS
46CO-AUTHORS
Medical devicesGene expression (incl. microarray and other genome-wide approaches)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 23, 2026
Discovery of a Highly Potent and Selective ENL Degrader.

|May 21, 2025
bamSliceR: a Bioconductor package for rapid, cross-cohort variant and allelic bias analysis.

Yizhou Peter Huang, Lauren Harmon, Eve Deering-Gardner

|Mar 15, 2025
Expression of ENL YEATS domain tumor mutations in nephrogenic or stromal lineage impairs kidney development.

Zhaoyu Xue, Hongwen Xuan, Kin Lau

|Jan 10, 2025
A multivalent engagement of ENL with MOZ.

Dustin C Becht, Karthik Selvam, Catherine Lachance

|Aug 28, 2024
A potent and selective ENL degrader suppresses oncogenic gene expression and leukemia progression.

Zhaoyu Xue, Lihuai Qin, Hongwen Xuan

|Feb 02, 2024
Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.

Oussama Abla, Rhonda E Ries, Tim Triche

Pageof 2

Frequent Collaborators

6 joint publications

Xiaobing Shi

4 joint publications

Tatiana G Kutateladze

3 joint publications

Zhaoyu Xue

3 joint publications

Timothy J Triche